Author:
Nair Sreenath,Selvo Nicholas S.,Stolarski Abigail,Klee Brandon,Federico Sara M.,Stewart Clinton F.
Funder
American Lebanese Syrian Associated Charities
National Institutes of Health
National Cancer Institute
Reference21 articles.
1. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11;Kawato;Cancer Res.,1991
2. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11);Mathijssen;Clin. Cancer Res.,2001
3. A phase I study of irinotecan in pediatric patients: a pediatric oncology group study;Blaney;Clin. Cancer Res.,2001
4. Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group;Vassal;J. Clin. Oncol.,2007
5. Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group Study;Bagatell;J. Clin. Oncol.,2011